[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100519164":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":41,"collaborators":10,"id":43,"slug":10,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":10,"eligibilityCriteria":48,"healthyVolunteers":44,"sex":49,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":10,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":10,"overallStatus":59,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Fujian Cancer Hospital","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"cervical cancer treated with surgery",null,"The inclusion criteria were: (1) pathologically confirmed CC; (2) FIGO stage IB-IIA according to the result of physical examination and imaging; (3) abdominal MRI was performed within three weeks before surgery. Exclusion criteria were: (1) accompanied with other tumors. (2) with chronic infectious disease. (3) incomplete clinical data.",[13],"Other: no intervention",[15],{"type":16,"name":17,"description":17,"armGroupLabels":18,"otherNames":10},"OTHER","no intervention",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Yang Sun, PHD","CONTACT","+8615959028989","sunyang@fjzlhospital.com",[26],{"facility":5,"status":10,"city":27,"state":28,"zip":29,"country":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Fuzhou","Fujian","350014","China",{"type":32,"coordinates":33},"Point",[34,35],119.30611,26.06139,{"lat":35,"lon":34},[38],{"name":39,"role":22,"phone":40,"phoneExt":10,"email":24},"Yang Sun","15959028989",{"type":42,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100519164",false,"NCT06039982","A Diagnostic Nomogram for Predicting Vaginal Invasion in Cervical Cancer","Establish a New Noninvasive Diagnostic Model Based on Clinical Indicators to Evaluate the Vaginal Invasion in Cervical Cancer Patients","Inclusion Criteria:\n\n* Pathologically confirmed cervical cancer;\n* FIGO2018 stage IB-IIA according to the result of physical examination and images;\n* No preoperative treatment before surgery;\n* Abdominal MRI is performed within three weeks before surgery. Blood routine, biochemistry, blood tumor markers and coagulation function were examined within 1 week before surgery.\n* All patients undergo radical hysterectomy (RH) with bilateral pelvic lymphadenectomy or paraaortic lymph node dissection.\n\nExclusion Criteria:\n\n* Accompanied with other tumors;\n* Accompanied with chronic infectious and immune diseases;\n* Incomplete clinical data.","FEMALE","18 Years","80 Years",{"count":53,"type":54},100,"ESTIMATED","OBSERVATIONAL","This study aims to develop a diagnostic nomogram based on clinical factors with the prediction values of vaginal invasion in cervical cancer to optimize the treatment plan and surgical procedures.",[58],"Cervix Carcinoma","NOT_YET_RECRUITING","2023-09-23",{"date":62,"type":63},"2023-09-26","ACTUAL",{"date":65,"type":54},"2023-11-01",{"date":67,"type":54},"2026-11-01",{"name":5,"class":6},1]